These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


73 related items for PubMed ID: 7582381

  • 1. The impact of long-term cyclosporin-A therapy on hematological and biochemical profile in renal transplant patients.
    Islam SI, Ezeamuzie CI, Shaheen FA, Sheikh IA, Masuda QN, Khaleel MH.
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):315-21. PubMed ID: 7582381
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 3. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 4. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 5. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

  • 6. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov 15; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 7. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M, Weinstein T, Korzets A, Chagnac A, Ori Y, Zevin D, Malachi T, Gafter U.
    J Lab Clin Med; 2001 Jan 15; 137(1):14-20. PubMed ID: 11150019
    [Abstract] [Full Text] [Related]

  • 8. Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens.
    McIntyre HD, Menzies B, Rigby R, Perry-Keene DA, Hawley CM, Hardie IR.
    Clin Transplant; 1995 Feb 15; 9(1):20-4. PubMed ID: 7742578
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C, Eberl T, Riedmann B, Pernthaler H, Ofner D, Königsrainer A, Margreiter R.
    Clin Transplant; 1996 Apr 15; 10(2):209-12. PubMed ID: 8664521
    [Abstract] [Full Text] [Related]

  • 10. Impact of time-interval after transplantation and therapy with fibrates on serum cholesterol levels in renal transplant patients.
    Fuhrer JA, Montandon A, Descoeudres C, Jaeger P, Horber FF.
    Clin Nephrol; 1993 May 15; 39(5):265-71. PubMed ID: 8513604
    [Abstract] [Full Text] [Related]

  • 11. Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus.
    White M, Ross H, Haddad H, LeBlanc MH, Racine N, Pflugfelder P, Giannetti N, Davies R, Azevedo E, Isaac D, Burton J, Ferguson R, Genest J.
    Transplantation; 2006 Sep 27; 82(6):763-70. PubMed ID: 17006323
    [Abstract] [Full Text] [Related]

  • 12. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P, Baron C, Fruchaud G, Hemery F, Desvaux D, Buisson C, Chopin D, Dahmane D, Remy P, Pastural M, Abbou C, Weil B, Lang P.
    Transpl Int; 2002 Nov 27; 15(11):550-5. PubMed ID: 12461659
    [Abstract] [Full Text] [Related]

  • 13. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K, Wójcicka-Bentyn J, Sieńko J, Grymowicz M, Smolarczyk R, Malinowska-Polubiec A, Romejko E.
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun 15; 114(2):155-61. PubMed ID: 15140508
    [Abstract] [Full Text] [Related]

  • 14. Detailed study of changes in renal function after conversion from cyclosporine to azathioprine.
    Hilbrands LB, Hoitsma AG, Wetzels JF, Koene RA.
    Clin Nephrol; 1996 Apr 15; 45(4):230-5. PubMed ID: 8861797
    [Abstract] [Full Text] [Related]

  • 15. [Clinical results of immunosuppressive triple therapies in living-related renal transplantation--a single center experience].
    Nagahama K, Yamamoto S, Yoshida H, Nakamura E, Ito N, Kinoshita H, Kamoto T, Okuno H, Ogawa O.
    Hinyokika Kiyo; 2004 Sep 15; 50(9):605-10. PubMed ID: 15518124
    [Abstract] [Full Text] [Related]

  • 16. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul 15; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
    Gallagher M, Jardine M, Perkovic V, Cass A, McDonald S, Petrie J, Eris J.
    Transplantation; 2009 Jun 27; 87(12):1877-83. PubMed ID: 19543068
    [Abstract] [Full Text] [Related]

  • 18. Retrospective study of the effects of cyclosporine in comparison with azathioprine on renal transplant recipients infected with hepatitis C virus.
    Ichikawa Y, Kishikawa H, Nishimura K, Tokugawa S, Yoshioka I, Arichi N, Fujii N, Kyo M, Nishikawa M.
    Transplant Proc; 2006 Dec 27; 38(10):3451-3. PubMed ID: 17175300
    [Abstract] [Full Text] [Related]

  • 19. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
    Morales JM, Campistol JM, Kreis H, Mourad G, Eris J, Schena FP, Grinyo JM, Nanni G, Andres A, Castaing N, Brault Y, Burke JT.
    Transplant Proc; 2005 Mar 27; 37(2):693-6. PubMed ID: 15848504
    [Abstract] [Full Text] [Related]

  • 20. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov 27; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.